Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke
- PMID: 32897811
- PMCID: PMC7530056
- DOI: 10.1161/STROKEAHA.120.030429
Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke
Abstract
Understanding the relationship between infection and stroke has taken on new urgency in the era of the coronavirus disease 2019 (COVID-19) pandemic. This association is not a new concept, as several infections have long been recognized to contribute to stroke risk. The association of infection and stroke is also bidirectional. Although infection can lead to stroke, stroke also induces immune suppression which increases risk of infection. Apart from their short-term effects, emerging evidence suggests that poststroke immune changes may also adversely affect long-term cognitive outcomes in patients with stroke, increasing the risk of poststroke neurodegeneration and dementia. Infections at the time of stroke may also increase immune dysregulation after the stroke, further exacerbating the risk of cognitive decline. This review will cover the role of acute infections, including respiratory infections such as COVID-19, as a trigger for stroke; the role of infectious burden, or the cumulative number of infections throughout life, as a contributor to long-term risk of atherosclerotic disease and stroke; immune dysregulation after stroke and its effect on the risk of stroke-associated infection; and the impact of infection at the time of a stroke on the immune reaction to brain injury and subsequent long-term cognitive and functional outcomes. Finally, we will present a model to conceptualize the many relationships among chronic and acute infections and their short- and long-term neurological consequences. This model will suggest several directions for future research.
Keywords: coronavirus; dementia; infection; pneumonia; risk factor; stroke.
Conflict of interest statement
Conflicts of Interest:
Dr. Elkind receives royalties from UpToDate for chapters on stroke and COVID-19.
Dr. Boehme declares no conflicts of interest.
Dr. Smith previously received honoraria from Sanofi, Pfizer and Boehringer Ingelheim, Inc. for activities unrelated to this article.
Dr. Meisel declares no conflicts of interest.
Dr. Buckwalter is on the advisory board of Omniox, Inc.
Figures


References
-
- Karenberg A, Hort I. Medieval descriptions and doctrines of stroke: preliminary analysis of select sources. Part I: The struggle for terms and theories - late antiquity and early Middle Ages. J Hist Neurosci. 1998;7:162–73. - PubMed
-
- Marie P Hémiplégie cérébrale infantile et maladies infectieuses. Prog Med. Paris; 1885;13:167–9.
-
- Ophüls W Arteriosclerosis and cardiovascular disease: their relation to infectious diseases. JAMA. 1921;76:700–1.
-
- Hindfelt B, Nilsson O. Brain infarction in young adults (with particular reference to pathogenesis). Acta Neurologica Scandinavica. 1977;55:145–57. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical